Exact Sciences, Bausch Health & more: 8 GI industry key notes

Here are eight updates from gastroenterology companies and practices from the past week: 

Bausch Health, Salix Pharmaceuticals and Alfasigma SpA filed a patent infringement lawsuit against Sandoz, a division of Novartis.

Exact Sciences' week started with a boom when the FDA expanded its approval for the company's noninvasive colon cancer test Cologuard to include the 45 to 49 age range. Cologuard President Mark Stenhouse elaborated on what the indication means to the company: Read more. 

Lakewood Ranch-based Florida Digestive Health Specialists added Avantika Mishra, MD, to its team.

Switzerland-based immuno-transcriptomics company Novigenix SA said its blood-based colorectal cancer test delivered encouraging results.

Takeda Pharmaceutical Co. is exploring a deal to sell several of its over-the-counter and prescription drugs in emerging markets and Western Europe.

The FDA cleared six new Fujifilm Medical Systems, U.S.A. endoscopic products.

Gastroenterology-focused pharmaceutical company Phantom Pharmaceuticals will appoint Terrie Curran as CEO after Celgene Corp. is acquired by Bristol-Myers Squibb.

Takeda and Evotec SE entered into a multiyear partnership to develop new drug therapies. 

More articles on surgery centers:
ASC supply chain tip of the day: Use an inventory module
3 ways to ensure smooth adoption of new ASC technology
NTT Data, Tenet partner to deliver technology services 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months